Haaretz latest headlines (RSS Feed) on Nostr: Unable to cure their kids' ultra-rare diseases, Israeli parents built company saving ...
Unable to cure their kids' ultra-rare diseases, Israeli parents built company saving others
The technology of QRGenetics identifies the activity of defective proteins in children with ultra-rare disease with no cure, and seeks out existing drugs for other uses – that may change the course of the disease. Despite a long list of remarkable successes, the company is still struggling for funding
https://www.haaretz.com/israel-news/culture/health/2025-01-13/ty-article-magazine/.premium/unable-to-cure-their-kids-ultra-rare-disease-israeli-parents-built-company-saving-others/00000194-5f9d-d2ad-a19d-7fdd82600000
The technology of QRGenetics identifies the activity of defective proteins in children with ultra-rare disease with no cure, and seeks out existing drugs for other uses – that may change the course of the disease. Despite a long list of remarkable successes, the company is still struggling for funding

https://www.haaretz.com/israel-news/culture/health/2025-01-13/ty-article-magazine/.premium/unable-to-cure-their-kids-ultra-rare-disease-israeli-parents-built-company-saving-others/00000194-5f9d-d2ad-a19d-7fdd82600000